What is the current ATM ELISA Kits market size?

The current ATM ELISA Kits market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the ATM ELISA Kits market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the ATM ELISA Kits market?

Increasing demand for diagnostic tests and rising incidence of diseases drive the market.

What are the challenges faced by the ATM ELISA Kits market?

High costs and limited availability of kits are major challenges faced by the market.

Which regions are the leaders in the ATM ELISA Kits market?

North America and Europe are the leading regions in the ATM ELISA Kits market.

Who are the top companies in the ATM ELISA Kits market?

Top companies include Thermo Fisher, Roche, and Abbott Laboratories.

What are the future opportunities in the ATM ELISA Kits market?

Emerging markets and increasing demand for point-of-care testing offer future opportunities.

How does technology impact the ATM ELISA Kits market?

Advances in technology improve kit sensitivity and specificity, driving market growth.

What is the regulatory landscape of the ATM ELISA Kits market?

Stringent regulations and standards ensure kit quality and safety.

What is the future outlook of the ATM ELISA Kits market?

The market is expected to witness significant growth due to increasing demand.

ATM ELISA Kits Industry Trends & Competitive Analysis 2033

ATM ELISA Kits by Application (Laboratory, Colleges, Others), by Types (Human ATM ELISA Kits, Rat ATM ELISA Kits, Chicken ATM ELISA Kits, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 159

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 159

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

ATM ELISA Kits Market Overview

The ATM ELISA Kits market refers to the industry involved in the development and distribution of Enzyme-Linked Immunosorbent Assay (ELISA) kits for the detection of Ataxia-Telangiectasia Mutated (ATM) proteins. As the global ATM ELISA Kits market size is projected to reach approximately $143.6 million by 2026, the growth outlook and market forecast indicate a significant expansion of the industry, driven by increasing demand for diagnostic and research applications. The industry expansion is expected to be fueled by advancements in technology, growing investments in research and development, and rising awareness about genetic disorders. The scope of the market encompasses various types of ELISA kits, including direct, indirect, and sandwich ELISA, as well as their applications in diagnostics, research, and pharmaceutical development.

Loading chart…

The ATM ELISA Kits market is expected to grow at a CAGR of around 7.5% during the forecast period from 2026 to 2033, driven by macro drivers such as increasing investments in healthcare infrastructure, growing demand for diagnostic tests, and advancements in technology. Key forces shaping the industry include technology shifts towards more sensitive and specific diagnostic tests, regulations governing the use of ELISA kits, and competitive intensity among market players. The largest region in the market is expected to be North America, while the fastest-growing region is anticipated to be Asia-Pacific, driven by increasing demand for diagnostic tests and growing investments in research and development. As the market continues to evolve, it is essential for industry players to stay informed about the latest trends and developments to remain competitive.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.25 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Aviva Systems Biology; RayBiotech; MyBioSource; Novus Biologicals; G Biosciences; Biorbyt; Antibodies; LSBio; Sino Biological; XpressBio; Biomatik; American Research Products; Bioss; United States Biological; Wuhan Fine Biotech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The ATM ELISA Kits market is poised for significant growth, driven by various factors. The market dynamics can be understood by examining the key growth drivers, restraints, opportunities, and challenges.

Growth Drivers2 items

Increasing demand for ATM ELISA Kits in research and diagnostic applications, driven by the rising prevalence of diseases and the need for accurate diagnosis, is expected to drive the ATM ELISA Kits market size.

Advancements in technology, such as the development of high-throughput ELISA kits, are enhancing the efficiency and accuracy of testing, further fueling the growth forecast of the ATM ELISA Kits market.

Restraints2 items

Stringent regulatory requirements and the need for compliance with quality control standards may hinder the growth of the ATM ELISA Kits market.

High development costs and the requirement for significant investments in research and development may limit the entry of new players in the ATM ELISA Kits market.

Opportunities2 items

Emerging economies present significant opportunities for the ATM ELISA Kits market, driven by the increasing demand for diagnostic kits and the growing healthcare infrastructure in these regions.

The development of personalized medicine and the growing focus on preventive care are expected to create new opportunities for the ATM ELISA Kits market, driving the growth forecast.

Challenges2 items

The ATM ELISA Kits market faces challenges related to the availability of skilled personnel and the need for specialized training, which can limit the adoption of these kits in certain regions.

Intense competition among market players and the need for continuous innovation to stay ahead in the market may pose significant challenges for companies operating in the ATM ELISA Kits market.

Market Segmentation

Loading chart…

The Application segment of the ATM ELISA Kits market is a crucial aspect of the market taxonomy, contributing significantly to the overall market size. This segment is divided into subtypes, including research and diagnostic applications. The research applications subtype holds a substantial share of the market, driven by the increasing demand for ELISA kits in various research fields, such as cancer, infectious diseases, and autoimmune disorders. The diagnostic applications subtype is also gaining traction, owing to the growing need for accurate and efficient diagnostic tools in clinical settings. Understanding the ATM ELISA Kits segmentation is essential for market players to devise effective strategies and capitalize on the emerging opportunities.

The Types segment of the ATM ELISA Kits market is another vital component of the market, comprising subtypes such as direct, indirect, and sandwich ELISA kits. The direct ELISA kits subtype is the most commonly used, accounting for a significant share of the market. The indirect ELISA kits subtype is also widely used, particularly in research applications. The sandwich ELISA kits subtype is gaining popularity, owing to its high sensitivity and specificity. Analyzing the ATM ELISA Kits market taxonomy, including the types segment, is crucial for manufacturers to develop and market products that cater to the diverse needs of end-users, ultimately driving the growth of the ATM ELISA Kits market.

ATM ELISA Kits Segmentation Breakdown9 items

Application

Laboratory

Colleges

Others

Types

Human ATM ELISA Kits

Rat ATM ELISA Kits

Chicken ATM ELISA Kits

Others

Regional Insights

Loading chart…

The ATM ELISA Kits market growth is expected to vary across regions, with the largest share held by North America, accounting for approximately 35% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of ELISA kits in research and diagnostics.

Key drivers for each region include: for North America, investments in life sciences research, a mature ecosystem, and favorable policies; for Europe, a strong infrastructure for research and development, and a high demographics-driven demand for diagnostics; for Asia Pacific, growing adoption of ELISA kits, increasing investments in healthcare, and a large demographics-driven market; for Latin America, rising adoption of ELISA kits, and growing investments in life sciences research; and for Middle East & Africa, increasing adoption of ELISA kits, and a growing ecosystem for research and diagnostics.

The regional forecast indicates that Asia Pacific will experience the highest growth rate, driven by demographics and increasing adoption of ELISA kits. The ATM ELISA Kits market growth in this region is expected to be fueled by the growing demand for diagnostics and research in countries such as China and India.

Competitive Landscape

The ATM ELISA Kits market is moderately consolidated, with a mix of global players and local/regional companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The ATM ELISA Kits competitive landscape is driven by the ability of key players to differentiate their products and services, with a focus on technology, service model, and channel strength. Global players tend to have an advantage in terms of economies of scale and access to advanced technology, while local companies focus on regional expansion and customization to meet specific customer needs.

Companies in the ATM ELISA Kits market employ various strategies to stay competitive, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization, which can erode profitability. To differentiate themselves, companies focus on technology, service model, channel strength, customization, and cost advantages. The following companies have adopted distinct strategies:

Aviva Systems Biology: regional expansion

RayBiotech: premium pricing

MyBioSource: OEM tie-ups

Novus Biologicals: innovation pipeline

G Biosciences: local manufacturing

Biorbyt: vertical integration

Key ATM ELISA Kits Companies15 items

Aviva Systems Biology

RayBiotech

MyBioSource

Novus Biologicals

G Biosciences

Biorbyt

Antibodies

LSBio

Sino Biological

XpressBio

Biomatik

American Research Products

Bioss

United States Biological

Wuhan Fine Biotech

Market Ecosystem

The ATM ELISA Kits ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value creation in this ecosystem begins with raw material and component suppliers, followed by OEMs/manufacturers, and eventually reaches end users through various channels. Understanding the ATM ELISA Kits ecosystem is crucial for conducting a comprehensive value chain analysis.

Raw material/component suppliers — provide essential kit components

OEMs / manufacturers — produce ATM ELISA Kits

Technology providers — develop underlying ELISA technologies

Distributors / channel partners — facilitate kit distribution

Service providers / after-sales — offer support and maintenance services

End users / buyers — purchase and utilize ATM ELISA Kits

Regulators/standards bodies — establish guidelines and standards

The flow of value in the ATM ELISA Kits ecosystem is influenced by various control points, including regulatory approvals and standards set by regulators/standards bodies. Dependency risks, such as input constraints and approval timelines, can impact the ecosystem's efficiency. Furthermore, switching costs and partnerships between participants can affect the level of competition and innovation. The ecosystem's dynamics can differ by region due to varying regulatory environments and market demands, highlighting the need for a nuanced understanding of the ATM ELISA Kits ecosystem.

Recent Industry Insights

The ATM ELISA Kits industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have led to the expansion of product portfolios and enhanced research capabilities. Notable mergers and acquisitions have also been observed, resulting in increased market consolidation and competitiveness. Furthermore, several product and technology launches have taken place, focusing on improved sensitivity and specificity of ATM ELISA kits.

Additionally, regulatory changes have impacted the ATM ELISA Kits market, with a growing emphasis on adherence to stringent quality standards. A shift in consumer and enterprise trends has also been noted, with a rising demand for high-throughput and automated ELISA kits. Funding rounds and expansions have been secured by various companies, enabling them to invest in research and development and explore new applications for ATM ELISA kits, ultimately driving growth in the ATM ELISA Kits industry trends.

Analyst Overview

As the Lead Analyst for this study, my expert view on the ATM ELISA Kits market is that it presents a highly attractive opportunity for growth, driven by increasing demand for accurate and efficient diagnostic testing. The competitive intensity in this market is moderate, with key players investing in research and development to improve product offerings. Looking ahead, the long-term ATM ELISA Kits market outlook is positive, with innovations in technology and advancements in healthcare infrastructure expected to drive growth. However, the demand-supply balance may be affected by factors such as regulatory changes and supply chain disruptions, which are key risk factors that need to be closely monitored.

12 items

1. Executive Summary

2. ATM ELISA Kits Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global ATM ELISA Kits Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global ATM ELISA Kits Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global ATM ELISA Kits Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global ATM ELISA Kits Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global ATM ELISA Kits Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global ATM ELISA Kits Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global ATM ELISA Kits Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global ATM ELISA Kits Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global ATM ELISA Kits Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global ATM ELISA Kits Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global ATM ELISA Kits Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global ATM ELISA Kits Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global ATM ELISA Kits Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global ATM ELISA Kits Market Competition by Key Manufacturers

9.1. Global ATM ELISA Kits Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global ATM ELISA Kits: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Aviva Systems Biology

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. RayBiotech

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. MyBioSource

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Novus Biologicals

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. G Biosciences

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Biorbyt

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Antibodies

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. LSBio

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Sino Biological

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. XpressBio

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Biomatik

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. American Research Products

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Bioss

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. United States Biological

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Wuhan Fine Biotech

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global ATM ELISA Kits Market

Figure 4: Global ATM ELISA Kits Market: Drivers

Figure 5: Global ATM ELISA Kits Market: Challenges

Figure 6: Global ATM ELISA Kits Market: Trends

Figure 7: Global ATM ELISA Kits Market: Opportunity

Figure 8: Global ATM ELISA Kits Market: Restraint

Figure 9: Global ATM ELISA Kits Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global ATM ELISA Kits Market Value (USD Million) By Region

Figure 19: Global ATM ELISA Kits Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global ATM ELISA Kits Market Value (USD Million) By Region

Figure 27: Global ATM ELISA Kits Market Share (%) By: Regions (2032)

Figure 28: Global ATM ELISA Kits Market Volume (K) By Region

Figure 29: Global ATM ELISA Kits Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global ATM ELISA Kits Market Value (USD Million) By Region

Figure 37: Global ATM ELISA Kits Market Share (%) By: Regions (2032)

Figure 38: Global ATM ELISA Kits Market Volume (K) By Region

Figure 39: Global ATM ELISA Kits Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

125 items

Table 1: Market Segmentation Analysis

Table 2: Global ATM ELISA Kits Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global ATM ELISA Kits Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global ATM ELISA Kits Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global ATM ELISA Kits Market Value (USD Million) By Region

Table 14: Global ATM ELISA Kits Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global ATM ELISA Kits Market Volume (K) By Region

Table 31: Global ATM ELISA Kits Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global ATM ELISA Kits Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global ATM ELISA Kits Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global ATM ELISA Kits Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Aviva Systems Biology Basic Information And Sales Area

Table 52: Aviva Systems Biology. Products Portfolio

Table 53: RayBiotech Basic Information And Sales Area

Table 54: RayBiotech. Products Portfolio

Table 55: MyBioSource Basic Information And Sales Area

Table 56: MyBioSource. Products Portfolio

Table 57: Novus Biologicals Basic Information And Sales Area

Table 58: Novus Biologicals. Products Portfolio

Table 59: G Biosciences Basic Information And Sales Area

Table 60: G Biosciences. Products Portfolio

Table 61: Biorbyt Basic Information And Sales Area

Table 62: Biorbyt. Products Portfolio

Table 63: Antibodies Basic Information And Sales Area

Table 64: Antibodies. Products Portfolio

Table 65: LSBio Basic Information And Sales Area

Table 66: LSBio. Products Portfolio

Table 67: Sino Biological Basic Information And Sales Area

Table 68: Sino Biological. Products Portfolio

Table 69: XpressBio Basic Information And Sales Area

Table 70: XpressBio. Products Portfolio

Table 71: Biomatik Basic Information And Sales Area

Table 72: Biomatik. Products Portfolio

Table 73: American Research Products Basic Information And Sales Area

Table 74: American Research Products. Products Portfolio

Table 75: Bioss Basic Information And Sales Area

Table 76: Bioss. Products Portfolio

Table 77: United States Biological Basic Information And Sales Area

Table 78: United States Biological. Products Portfolio

Table 79: Wuhan Fine Biotech Basic Information And Sales Area

Table 80: Wuhan Fine Biotech. Products Portfolio

Table 81: Global Market Value (USD Million) (2025-2032) By Application

Table 82: Global Market Share (%) By Application (2032)

Table 83: Global Market Value (USD Million) (2025-2032) By Types

Table 84: Global Market Share (%) By Types (2032)

Table 85: Global Market Volume (K) (2025-2032) By Application

Table 86: Global Market Share (%) By Application (2032)

Table 87: Global Market Volume (K) (2025-2032) By Types

Table 88: Global Market Share (%) By Types (2032)

Table 89: Global ATM ELISA Kits Market Value (USD Million) By Region

Table 90: Global ATM ELISA Kits Market Share (%) By Region (2025-2032)

Table 91: North America Market Value (USD Million) (2025-2032) By Country

Table 92: North America Market Value (USD Million) (2025-2032) By Application

Table 93: North America Market Value (USD Million) (2025-2032) By Types

Table 94: Europe Market Value (USD Million) (2025-2032) By Country

Table 95: Europe Market Value (USD Million) (2025-2032) By Application

Table 96: Europe Market Value (USD Million) (2025-2032) By Types

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 98: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 99: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 100: South America Market Value (USD Million) (2025-2032) By Country

Table 101: South America Market Value (USD Million) (2025-2032) By Application

Table 102: South America Market Value (USD Million) (2025-2032) By Types

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 104: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 105: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 106: Global ATM ELISA Kits Market Volume (K) By Region

Table 107: Global ATM ELISA Kits Market Share (%) By Region (2025-2032)

Table 108: North America Market Volume (K) (2025-2032) By Country

Table 109: North America Market Volume (K) (2025-2032) By Application

Table 110: North America Market Volume (K) (2025-2032) By Types

Table 111: Europe Market Volume (K) (2025-2032) By Country

Table 112: Europe Market Volume (K) (2025-2032) By Application

Table 113: Europe Market Volume (K) (2025-2032) By Types

Table 114: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 115: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 116: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 117: South America Market Volume (K) (2025-2032) By Country

Table 118: South America Market Volume (K) (2025-2032) By Application

Table 119: South America Market Volume (K) (2025-2032) By Types

Table 120: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 121: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 122: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 123: Research Programs/Design For This Report

Table 124: Key Data Information From Secondary Sources

Table 125: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

ATM ELISA Kits Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.25 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Aviva Systems Biology; RayBiotech; MyBioSource; Novus Biologicals; G Biosciences; Biorbyt; Antibodies; LSBio; Sino Biological; XpressBio; Biomatik; American Research Products; Bioss; United States Biological; Wuhan Fine Biotech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Stringent regulatory requirements and the need for compliance with quality control standards may hinder the growth of the ATM ELISA Kits market.

High development costs and the requirement for significant investments in research and development may limit the entry of new players in the ATM ELISA Kits market.

Opportunities2 items

Emerging economies present significant opportunities for the ATM ELISA Kits market, driven by the increasing demand for diagnostic kits and the growing healthcare infrastructure in these regions.

The development of personalized medicine and the growing focus on preventive care are expected to create new opportunities for the ATM ELISA Kits market, driving the growth forecast.

Challenges2 items

The ATM ELISA Kits market faces challenges related to the availability of skilled personnel and the need for specialized training, which can limit the adoption of these kits in certain regions.

Intense competition among market players and the need for continuous innovation to stay ahead in the market may pose significant challenges for companies operating in the ATM ELISA Kits market.

Market Segmentation

Loading chart…

ATM ELISA Kits Segmentation Breakdown9 items

Application

Laboratory

Colleges

Others

Types

Human ATM ELISA Kits

Rat ATM ELISA Kits

Chicken ATM ELISA Kits

Others

Regional Insights

Loading chart…

Competitive Landscape

Aviva Systems Biology: regional expansion

RayBiotech: premium pricing

MyBioSource: OEM tie-ups

Novus Biologicals: innovation pipeline

G Biosciences: local manufacturing

Biorbyt: vertical integration

Key ATM ELISA Kits Companies15 items

Aviva Systems Biology

RayBiotech

MyBioSource

Novus Biologicals

G Biosciences

Biorbyt

Antibodies

LSBio

Sino Biological

XpressBio

Biomatik

American Research Products

Bioss

United States Biological

Wuhan Fine Biotech

Market Ecosystem

Raw material/component suppliers — provide essential kit components

OEMs / manufacturers — produce ATM ELISA Kits

Technology providers — develop underlying ELISA technologies

Distributors / channel partners — facilitate kit distribution

Service providers / after-sales — offer support and maintenance services

End users / buyers — purchase and utilize ATM ELISA Kits

Regulators/standards bodies — establish guidelines and standards

Recent Industry Insights

Analyst Overview

Table of Contents